Whether it was Amazon's buy of One Medical or CVS Health's acquisition of Signify Health, retailers made waves in healthcare this year. Across all of the deals, it's clear that expanding access to medical services is the key goal, experts said. And this is only the beginning.
Join Us at INVEST 2023 for an engaging 3 days of networking and discussions that focus on how the industry is evolving, emerging trends and game changers, outcomes and more.
As hospitals continue to battle healthcare's workforce shortage and high levels of staff turnover, capacity is a significant pain point. When it comes to technology to help optimize capacity management, hospital leaders want solutions that can automatically identify and prioritize patients who are ready for discharge using real-time data, according to a new report.
By Frank Vinluan Monday, December 19, 2022 6:37 PM
A Ferring Pharmaceuticals gene therapy is now FDA approved for treating bladder cancer that does not respond to an immunotherapy used to treat the cancer in its early stages. The Ferring gene therapy, Adstiladrin, turns bladder wall cells into tiny factories churning out a cancer-fighting therapeutic protein.
By Marissa Plescia Monday, December 19, 2022 5:58 PM
An Oscar Health survey found that about 93% of respondents are "extremely," "very" or "somewhat" concerned about the state of the economy. Another 44% of respondents listed the economy as their top healthcare concern.
Healthcare journalists source a significant amount of the stories they write from emailed pitches. To make the media relations process more fruitful for everyone involved, I laid out my top seven pet peeves as a healthcare technology reporter so public relations representatives have a better understanding of which behavior to avoid.
By Frank Vinluan Monday, December 19, 2022 1:32 PM
A Madrigal Pharmaceuticals drug for the fatty liver disease NASH has data from a pivotal clinical trial showing improvements in the organ. Based on those results, which sent Madrigal's stock price soaring more than 200%, the biotech is planning to seek what could become the first regulatory approval of a therapy for this metabolic disorder.
Through effective and purposeful engagement, frontline caregivers are able to build meaningful relationships with patients, show them that they are seen and heard, and empower them with the information and education they need to be better stewards of their own health.
Historically, clinical trials have not prioritized the experiences of patients, who are required to frequently return on-site and engage with unfamiliar medical technology. They are often left in the dark regarding the data and health outcomes being collected through their participation.
By Dr. Reza Hosseini Ghomi Monday, December 19, 2022 10:46 AM
By 2050 the cost of dementia in the US alone could rise to $1.1 trillion per year. Now more than ever it is critical to address the needs of individuals and families living with dementia. Fortunately, new diagnostic and treatment discoveries are paving the way for significant advancements.
By Laura Templeton Monday, December 19, 2022 9:07 AM
CMS is to be recognized for taking action to establishing chaplaincy codes along with other core services so that hospice claims data on spiritual care can be collected.
Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments